SCHEMBL526907

SCHEMBL526907

O=C(Nc1ccccc1)c1cc(Br)c(Br)c(Br)c1O.[Zn]

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPD1 P10809 2/20 0.66
HSPE1 P61604 2/20 0.66
KMT2A Q03164 7/20 0.51
MEN1 O00255 6/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
HPGD P15428 2/20 0.51
KDM4E B2RXH2 1/20 0.51
TP53 P04637 1/20 0.51
HSD17B10 Q99714 1/20 0.51
BCL2 P10415 2/20 0.51
ALDH1A1 P00352 2/20 0.51
MAPT P10636 2/20 0.51
EGFR P00533 1/20 0.51
ERBB2 P04626 1/20 0.51
CYP1A2 P05177 1/20 0.51
LCK P06239 1/20 0.51
CYP2C9 P11712 1/20 0.51
PTGS1 P23219 1/20 0.51
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833241 1.00 HSPD1 (0.66) HSPD1HSPE1KMT2AMEN1LMNA
SCHEMBL29474808 0.98 HSPD1 (0.68) HSPD1HSPE1KMT2AMEN1LMNA
SCHEMBL229763 0.98 HSPD1 (0.68) HSPD1HSPE1KMT2AMEN1LMNA
SCHEMBL5805742 0.97 HSPD1 (0.66) HSPD1HSPE1KMT2AMEN1LMNA
Phosphoric Acid SCHEMBL7515151 0.96 HSPD1 (0.61) HSPD1HSPE1KMT2AMEN1LMNA
Phosphoric Acid SCHEMBL7515153 0.91 HSPD1 (0.59) HSPD1HSPE1KMT2AMEN1LMNA
SCHEMBL28497138 0.81 HSPD1 (0.58) HSPD1HSPE1KMT2AMEN1LMNA
SCHEMBL22767660 0.81 HSPD1 (0.66) HSPD1HSPE1KMT2AMEN1LMNA
SCHEMBL3441192 0.81 HSPD1 (0.60) HSPD1HSPE1KMT2AMEN1LMNA
Metabromsalan SCHEMBL1162534 0.79 HSPD1 (1.00) HSPD1HSPE1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000000166-A2 IMPROVED ORAL COMPOSITIONS FOR CONTROL AND PREVENTION OF TARTAR, ORAL MALODOR, PLAQUE AND GINGIVITIS WARNER-LAMBERT COMPANY (US) 2000-01-06 WO claimed
US-4100269-A ZINC COMPOUND LEVER BROTHERS COMPANY (US) 1978-07-11 US claimed
US-20210196587-A1 Oral Compositions Comprising Zinc Citrate and/or Tocopherol Agents COLGATE-PALMOLIVE COMPANY (US) 2021-07-01 US disclosed
EP-1962778-B1 IMPROVED ORAL COMPOSITIONS COMPRISING ZINC CITRATE COLGATE PALMOLIVE CO (US) 2017-08-23 EP disclosed
EP-2598108-B1 PHOSPHATE FREE ORAL CARE COMPOSITIONS BASED ON MAGNOLIA ANTIBACTERIAL AGENT COLGATE PALMOLIVE CO (US) 2017-07-26 EP disclosed
US-9625449-B2 Determining the bioavailability of zinc (II) ions COLGATE-PALMOLIVE COMPANY (US) 2017-04-18 US disclosed
US-9435745-B2 Measuring the rate of release of metal ions COLGATE-PALMOLIVE COMPANY (US) 2016-09-06 US disclosed
US-20160178527-A1 MEASURING THE RATE OF RELEASE OF METAL IONS COLGATE-PALMOLIVE COMPANY 2016-06-23 US disclosed
US-20160178617-A1 DETERMINING THE BIOAVAILABILITY OF ZINC (II) IONS COLGATE-PALMOLIVE COMPANY 2016-06-23 US disclosed
US-9242125-B2 Oral composition containing non-aggregated zinc nanoparticles COGLATE-PALMOLIVE COMPANY (US) 2016-01-26 US disclosed
US-9125860-B2 Phosphate free oral care compositions based on magnolia antibacterial agent COLGATE-PALMOLIVE COMPANY (US) 2015-09-08 US disclosed
EP-1962778-A2 IMPROVED ORAL COMPOSITIONS COMPRISING ZINC CITRATE AND/OR TOCOPHEROL AGENTS Colgate-Palmolive Company (US) 2008-09-03 EP disclosed
EP-1904025-A1 ORAL COMPOSITION CONTAINING NON-AGGREGATED ZINC NANOPARTICLES Colgate-Palmolive Company (US) 2008-04-02 EP disclosed
US-20070183989-A1 Oral Compositions Comprising Zinc Citrate and/or Tocopherol Agents COLGATE-PALMOLIVE COMPANY 2007-08-09 US disclosed
WO-2007076444-A2 IMPROVED ORAL COMPOSITIONS COMPRISING ZINC CITRATE AND/OR TOCOPHEROL AGENTS COLGATE-PALMOLIVE COMPANY (US) 2007-07-05 WO disclosed
WO-2007013937-A1 ORAL COMPOSITION CONTAINING NON-AGGREGATED ZINC NANOPARTICLES COLGATE-PALMOLIVE COMPANY (US) 2007-02-01 WO disclosed
US-20070020201-A1 Oral composition containing non-aggregated zinc nanoparticles COLGATE-PALMOLIVE COMPANY 2007-01-25 US disclosed
US-6221340-B1 ZINC CITRATE, A BUFFER SYSTEM, AN ABRASIVE; AND AN ORAL VEHICLE, WHEREIN THE DENTIFRICE COMPOSITION HAS A PH FROM ABOUT 3.0 TO ABOUT 5.5, THE ZINC CITRATE IS IN AN AMOUNT SUFFICIENT TO PROVIDE AT LEAST ABOUT 2000 PPM OF ZINC ION WARNER-LAMBERT COMPANY 2001-04-24 US disclosed
US-5880076-A PERSONAL PRODUCT OR DETERGENT COMPOSITION COMPRISING CYCLIC GLYCACARBAMATE AND/OR GLYCAUREA, SURFACTANT LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1999-03-09 US disclosed
US-4100269-A ZINC COMPOUND LEVER BROTHERS COMPANY (US) 1978-07-11 US disclosed